SHENZHEN BANGMA TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN BANGMA TECHNOLOGY CO., LTD. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include BMOR, MEIYE, VAPTEX, VAPINEO, and B. B + MOR. The owner is based in SHENZHEN GUANGDONG.
A1,FLOOR 2,WORKSHOP C,HOUTING XUEZIWEI
INDUSTRIAL PARK,SHAJING ST,BAOAN DIST,
SHENZHEN GUANGDONG 518104 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN BANGMA TECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does SHENZHEN BANGMA TECHNOLOGY CO., LTD. have?
SHENZHEN BANGMA TECHNOLOGY CO., LTD. has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 abandoned.
What trademark classes does SHENZHEN BANGMA TECHNOLOGY CO., LTD. file in?
SHENZHEN BANGMA TECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 34 (Smokers Articles), Class 35 (Advertising & Business). Class 34 covers tobacco; smokers articles; matches.
What are SHENZHEN BANGMA TECHNOLOGY CO., LTD.'s most well-known trademarks?
SHENZHEN BANGMA TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as BMOR, MEIYE, VAPTEX, VAPINEO, and B. B + MOR. These are among 5 currently registered trademarks in the portfolio.
What is SHENZHEN BANGMA TECHNOLOGY CO., LTD.'s trademark registration success rate?
SHENZHEN BANGMA TECHNOLOGY CO., LTD. has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.